Home / Products / Cancer (Tumor) Cell Lines / MFE-280
MFE-280
Datasheet Protocol

MFE-280

Cat. No. ARC0512
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Uterus (endometrium)

Growth Properties:

Adherent

In stock
$2,300.00 / Vial
Ask a Question

Short Description 🔒

MFE-280 is a cancer cell line of uterus (endometrium) adenocarcinoma, isolated from in situ; endometrium.

Recommended Products

MAN2A1 Knockout jurkat Polyclonal Cells MAN2A1 Knockout jurkat Polyclonal Cells Cat. No. ARG13506 HMOX1 Knockout MES-OV Polyclonal Cells HMOX1 Knockout MES-OV Polyclonal Cells Cat. No. ARG24556 KRT85 Knockout Hela Polyclonal Cells KRT85 Knockout Hela Polyclonal Cells Cat. No. ARG26526 NADK2 Knockout 786-O Polyclonal Cells NADK2 Knockout 786-O Polyclonal Cells Cat. No. ARG5055 MTHFD2 Knockout HEK293T Polyclonal Cells MTHFD2 Knockout HEK293T Polyclonal Cells Cat. No. ARG4537 PABPC1L Knockout AGS Polyclonal Cells PABPC1L Knockout AGS Polyclonal Cells Cat. No. ARG3030
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Uterus (endometrium)
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
77 years
Sex of Donor:
Female
Derived From Site:
In situ; Endometrium
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

FGA Knockout Lovo Polyclonal Cells

FGA Knockout Lovo Polyclonal Cells

Cat. No. ARG11681
 ATAD2B Knockout 786-O Polyclonal Cells

ATAD2B Knockout 786-O Polyclonal Cells

Cat. No. ARG25012
 AK3 Knockout NCI-H1299 Polyclonal Cells

AK3 Knockout NCI-H1299 Polyclonal Cells

Cat. No. ARG30280
 IMPACT Knockout HT29 Polyclonal Cells

IMPACT Knockout HT29 Polyclonal Cells

Cat. No. ARG33448
 ABLIM3 Knockout HAP1 Polyclonal Cells

ABLIM3 Knockout HAP1 Polyclonal Cells

Cat. No. ARG21569
 FTO Knockout CaSki Polyclonal Cells

FTO Knockout CaSki Polyclonal Cells

Cat. No. ARG9826